Hepatitis C in Lebanon: burden of the disease and value of comprehensive screening and treatment
Conclusion: An enhanced screening policy coupled with broader access to DAAs will diminish the future burden of HCV in the Lebanese population and provide the greatest health benefits among middle-aged and elder adults with net cost savings.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Clinical Trials | Epidemiology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Insurance | Lebanon Health | Liver | Liver Cancer | Middle East Health | Urology & Nephrology | Virology